Shiqi Wu
Jiangsu Key Laboratory Of Drug Design And Optimization
Nanjing, 211198, China
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of Novel and Potent Dual PARP1/ERK Inhibitors as a Promising Strategy for Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: February 25, 2026
In vitro and ex vivo Pharmacological Profile of HY-022619, a Novel Intravenous P2Y12 Receptor Antagonist with Rapid-onset and Sustained Antiplatelet Activity.
Journal: Pharmaceutical research
Published: December 11, 2025
Novel 3-n-butylphthalide derivatives as potent multi-functional anti-IS agents with BBB protective function.
Journal: Bioorganic chemistry
Published: August 13, 2025
Discovery of Orally Potent Small-Molecule CD73 Inhibitor for Cancer Immunotherapy.
Journal: Journal of medicinal chemistry
Published: May 23, 2025
Discovery and Optimization of Potent and Highly Selective PARP14 Inhibitors for the Treatment of Atopic Dermatitis.
Journal: Journal of medicinal chemistry
Published: April 16, 2025
Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative review.
Journal: Translational cancer research
Published: February 13, 2025
Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitis.
Journal: Bioorganic & medicinal chemistry letters
Published: January 02, 2025
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.
Journal: Journal of medicinal chemistry
Published: February 13, 2024
Early Warning of Gas Concentration in Coal Mines Production Based on Probability Density Machine.
Journal: Sensors (Basel, Switzerland)
Published: July 06, 2021
Discovery of Novel Dual Extracellular Regulated Protein Kinases (ERK) and Phosphoinositide 3-Kinase (PI3K) Inhibitors as a Promising Strategy for Cancer Therapy.
Journal: Molecules (Basel, Switzerland)
Published: October 29, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026